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(a) Penemuan Projek/Abstrak 
ABSTRACT 
We studied three different target blood concentrations (TBC) of propofol for 
induction of anaesthesia using target controlled infusion (TCI) technique. One hundred 
and thirty five ASA I and II patients, between 18-55 years of age and undergoing any type 
of elective surgery were included in the study. All patients were premedicated with oral 
midazolam 7.5 mg in the ward an hour before induction. Patients were randomly divided 
into three groups. Group I (n = 45) received initial TBC of 2 J,Jg/ml, group II (n = 45) TBC 
of 3 J.Jg/ml and group Ill (n = 45) TBC of 4 J,Jg/ml for induction of anaesthesia. Intravenous 
alfentanil 30 ~g/kg bolus was given as analgesia. Patients were observed for success 
rate of induction, induction time, effect site concentration and haemodynamic parameters 
at baseline, 1 minute, 3 minutes and 5 minutes after induction. 
Success rate of induction was 55.6 %, 86.7% and 91.1 %in group I, 11 and 111 
respectively, which showed significant difference only between group I and Ill. Effect site 
concentration was 0.6 ~g/ml, 0.9 J,Jg/ml and 0.8 JJQ/ml in group I, II and Ill respectively 
which showed significant difference only between group I and II. There was no significant 
difference in induction time and haemodynamic parameters among the three groups. 
Hence, TBC 3 J,Jg/ml was comparable with TBC 4 J.Jg/ml for induction of 
anaesthesia using TCI technique. However TBC 2 IJQ/ml was not recommended for rapid 
induction. 
ABSTRAK 
Kami mengkaji tiga sasaran kepekatan dalam darah (SKD) yang berbeza bagi 
propofol dalam menghasilkan permulaan kesan bius (induksi) menggunakan teknik infusi 
kawalan sasaran (IKS). 135 pesakit dalam klasifikasi ASA I dan II, berumur di antara 18-
55 tahun dan menjalani sebarang pembedahan yang dijadualkan, telah dimasukkan ke 
dalam kajian. Semua pesakit diberikan ubat midazolam 7.5 mg secara oral di dalam wad 
satu jam sebelum permulaan bius Pesakit dibahagikan secara rawak kepada 3 
kumpulan. Kumpulan I (n= 45) menerima SKD permulaan 2 IJQ/ml, kumpulan II (n=45) 
menerima permulaan SKD 3 IJQ/ml dan kumpulan Ill (n=45) menerima permulaan SKD 4 
IJQ/ml untuk menghasilkan induksi pembiusan. Ubat alfentanil 30 IJg/kg diberi sebagai 
ubat penahan sakit secara suntikan melalui salur darah (intravena). Pesakit dinilai untuk 
kadar kejayaan untuk induksi bius, masa induksi, kepekatan pada tempat sasaran dan 
parameter hemodinamik direkodkan pada bacaan dasar, 1 minit, 3 minit dan 5 minit 
selepas induksi. 
Kadar kejayaan induksi ialah 55.6 %, 86.7 % dan 91.1 % bagi masing-masing 
kumpulan I, II dan Ill yang mana perbezaan yang bererti hanya ditunjukkan di antara 
kumpulan I dan Ill. Kepekatan pada tempat sasaran ialah 0.6 f,Jg/ml, 0.9 IJg/ml dan 0.8 
IJQ/ml bagi masing-masing kumpulan I, II dan Ill yang mana perbezaan yang bererti 
hanya ditunjukkan di antara kumpulan I dan II. Tiada sebarang perbezaan bererti untuk 
masa induksi dan kesemua parameter hemodinamik. 
Oleh itu, SKD 3 f.Jg/ml adalah setara jika dibandingkan dengan SKD 4 IJQ/ml 
untuk induksi pembiusan menggunakan teknik IKS. Walau bagaimanapun SKD 2 IJQ/ml 
tidak disarankan untuk permulaan induksi bius yang cepat. 
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CONCENTRATiO NS O F PRO POFOL FOR GEN ERAL 
ANAESTH ESIA USIN G TARGET CONTROllED 
INFUSION (TCI) TECH N IQ UE. 
W.H. W Mohd Nazaruddin, H. Shamsulkamaruljan, N.M. Nik Abdullah 
Department of Anaesthesiology, School of Medical Sciences, Universiti Sains Malaysia, 
Kelantan, Malaysia. · 
Background : General recommendations for· initial target blood concentration (TBC) of propofol 
fo r general anaesthesia using TCI technique in premedicated patients is 4 ~tg/m l. 
Objectives : To compare success rate of induction withi n 3 minutes, induction time and 
haemodynamic changes between three different TBC. 
Methodology: In this prospective study, 135 ASA I and II patients in age between 18-55 years old 
and underwent any elective surgery were randomized into 3 groups. Group I received initial TBC 
of 2 ~g/ml (n = 45), group II received initial TBC of 3 ~g/ml (n = 45) and group Ill received initial 
TBC of 4 ~g/ml _ (n = 45) for induction of anaesthesia. All patients were premedicated with oral 
midazolam 7.5 mg in the ward 30 minutes before induction and were given IV alfentan il 30 ~g/kg 
bolus as an analgesia. Induction time was measured from starting of infusion until loss of verbal 
contact and induction was considered successful if loss of verbal contact was achieved within 3 
minutes from starting of infusion. Haemodynamic parameters (SBP. DBP, MAP and HR) were 
recorded at baseline, I minutes, 3 minutes and 5 minutes after induction. Patients were 
subsequently paralyzed with IV rocuronium 0.6 mg/kg and intubated. Maintenance of anaesthesia 
was continued with total intravenous anaesthesia using TCI of propofol at TBC of 3-6 ~g/ml and 
alfentanil infusion at 30-60 ~g/kg/h. 
Results: Success rate of induction was 55.6 % in TBC 2 ~tg/ml, 86.7% in TBC 3 ~g/ml and 91.1 % 
in TBC 4 ~g/ml which showed a significant difference•between 3 groups (p < 0.05lj However from 
multi variate analysis using logistic regression test, success rate was only significantly difference 
between TBC 2 ~g/ml and TBC 4 ~g/ml (p < 0.05) but was not.significantly diffe renc;.e between 
TBC 3 ~g/ml and TBC 4 pg/ml. Estimated marginal mean~ of induction t ime was 73.63 ± 7.33 s in 
TBC 2 ~g/ml. 74. 12 ± 5.81 s in TBC 3 ~g/ml and 55.25 ± 7.30 s in TBC 4 ~g/ml which showed no 
significant differences (p > 0.05). There was also no significant d ifferences in all haemodynamic 
changes between 3 groups. 
Conclusions : TBC 3 ~g/ml was comparable with TBC 4 ~g/ml for induction of anaesthesia with 
no significant differences in success rate of induction,_ induction time or haemodynamic changes. 
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Background: General recommendation for initial target blood concentration (TBC) 
of propofol for induction of anaesthesia using TCI technique in premedicated 
patients is 4 J,Jg/ml. 
Objectives: To compare success rate of induction within 3 minutes, induction time 
and haemodynamic changes between three different TBC of propofol. 
Methodology: In this prospective study, 135 ASA I and II patients in age between 
18-55 years old and underwent any elective surgery were randomized into 3 
groups. Group I receiveQ initial TBC of 2 J,Jg/ml (n = 45), group II .received initial 
TBC of 3 J,Jg/ml (n = 45) and group-Ill received initial TBC of 4 J,Jg/ml (n = 45) for 
induction of anaesthesia. All patients were premedicated with oral midazolam 7.5 
mg in the ward 30 minutes before induction and were given IV alfentanil 30 IJg/kg 
bolus as analgesia. Induction time was measured from starting of infusion until 
loss of verbal contact and induction was considered successful if loss of verba·l 
contact was achieved within 3'minutes from starting of infusion. Haemodynamic 
parameters (SBP, DBP, MAP and HR) were recorded at baseline, 1 minutes, 3 
minutes and 5 minutes after induction. Patients were subsequently paralyzed with 
IV rocuronium 0.6 mg/kg and intubated. Maintenance of anaesthesia was continued 
with total intravenous anaesthesia using TCI of propofol at TBC of 1.5-6 IJQ/ml 
and alfentanil infusion at 30-60 f.Jg/kg/h. 
Results: Success rate of induction was 55.6% in TBC 2 · ml, 86.7% in TBC 3 
IJg/ml and 91.1% in TBC 4 IJQ(.nl, which showed sig difference between ) 
3 groups (p = 0.000). Howevelfo.m r:nultivaria~e analysis l~gistic regression 
method, success rate were ori~lgmficantly difference TBC 2 IJg/ml and 
TBC 4 J,Jg/ml (p = 0.001) but w. not significantly d TBC 3 IJg/ml 
and TBC 4 IJg/ml (p = 0.898f .. · stimated marginal . 95% confidence 
interval of induction time were ~J.63 (59.08, 88.18) s in TB I, 7 4.12 (62.58, 
85.65} sin TBC 3 JJg/ml and 5~5 (40.76, 69.75} sin TBC which showed 
no significant difference (p = lf+o1.}. There were signifi es within all 
haemodynamic parameters bl"o si~nificant differences the groups. 
1-~~.; . ~~ • 
Conclusi~ns:_TBC 3_JJ~/ml ~'~ compara~le with TBC 4 U9!ml for induction of 
~naesthes1a w1th no S1~n1fica~1fferences 1n suc~ess rate qf1nduction, induction 
!1me ~r haemodynam1c chan'~.· .. s. TBC 2 IJQ/ml 1s not reQQJTirnended for initial 
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Comparison of Three Different Target Blood Concentrations of 
Propofol for Induction of Anaesthesia Using Target Controlled Infusion 
(TCI) Technique. 
W. H. W. M. Nazaruddin, H. Shamsulkamaruljan, N. M Nik Abdullah 
Department of Anaesthesiology and Intensive Care, School of Medical Sciences, 
Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. 
ABSTRACT 
We studied three different target blood concentrations (TBC) of propofol for 
induction of anaesthesia using target controlled infusion (TCI) technique. One hundred 
and thirty five ASA I and II patients, between 18-55 years of age and undergoing any 
type of elective surgery were included in the study. All patients were premedicated with 
oral midazolam 7.5 mg in the ward an hour before induction. Patients were randomly 
divided into three groups. Group I (n = 45) received initial TBC of 2 JJ.g/ml, group II (n = 
45) TBC of 3 J.lg/ml and group III (n = 45) TBC of 4 J.lg/ml for induction of anaesthesia. 
Intravenous alfentanil 30 J.lg/kg bolus was given as analgesia. Patients were observed for 
success rate of induction, induction time, effect site concentration and haemodynamic 
parameters at baseline, I minute, 3 minutes and 5 minutes after induction. 
Success rate of induction was 55.6 %, 86.7% and 91.1 %in group I, II and III 
respectively, which showed significant difference only between group I and III. Effect 
site concentration was 0.6 J.lg/ml, 0.9 J.lg/ml and 0.8 JJ.g/ml in group I, II and 111 
respectively which showed significant difference only between group I and II. There was 
1 
no significant difference in induction time and haemodynamic parameters among the 
three groups. 
Hence, TBC 3 J.lg/ml was comparable with TBC 4 J.lg/ml for induction of 
anaesthesia using TCI technique. However TBC 2 J.lg/ml was not recommended for rapid 
induction. 
Keywords: Target controlled infusion, propofol, induction of anaesthesia, target blood 
concentration 
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INTRODUCTION 
Propofol is a fast-acting intravenous (N) drug with a favourable pharmacokinetic profile 
for inducing and maintaining total IV anaesthesia. The development of computer-assisted 
target controlled infusion (TCI) system has given a new dimension to administer propofol 
infusion and provide the anaesthesiologist with a convenient method for directly 
controlling the blood concentration of anaesthetics•. TCI systems for propofol use a 
special infusion pump which is incorporated with 'Diprifusor' software1-.z. This software 
consists of three-compartment phannacokinetic model with a specific set of 
phannacokinetic parameters for propofol and two independent infusion control 
algorithms •-.z. 
In general, the recommendation by manufacturer of target blood concentration 
(TBC) of propofol for induction is 4-8 ~g/ml. TBC of 4 ~g/ml was recommended in 
premedicated patients and 6 ~g/ml in unpremedicated patients (4). However, there is a 
wide interindividual phannacokinetic and pharmacodynamic variability in propofol 
requirement. By giving an intravenous dose of propofol 2 mglkg, resulted in a peak blood 
concentration that varied from 5-8 ~g/ml between patients, thereby exhibiting different 
effects in different patients2• Some patients only required effect-site concentrations of 
propofol 1.5 ~g/ml for induction of anaesthesia whereas others required more than 6 
J.lg/ml (5). Even with inclusion of covariates (age and body weight), the interindividual 
variabilities remained relatively large, indicating a large variance of pharmacokinetics 
among patients ( 6). In view of a wide interindividual pharmacokinetic and 
3 
pharmacodynamic variability in propofol, there are also possible wide differences of 
phannacological responses to propofol in our population. 
The aim of this study was to determine TBC of propofol for induction of 
anaesthesia using TCI technique in our population in comparison with recommendation 
from the previous studies by comparing the success rate of induction within 3 minutes, 
induction time and haemodynamic changes between three different TBC of propofol (2, 3 
and 4 J.lg/ml). 
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MATERIALS AND METHODS 
After Institutional Ethics Committee approval, written concent was obtained from 135 
ASA I and II patients, aged between 18-55 years old, scheduled for any type of elective 
surgery under general anaesthesia with an expected duration of less than 5 hours. Patients 
with a history of allergy to trial drugs or its constituents, pregnant women and obese 
patients (> 120 % of ideal body weight) were excluded from the study. 
All patients were premedicated with oral midazolam 7.5 mg in the ward just 
before sending patients to the operation theatre (OT) which was about 1 hour before 
induction. The patients were randomly allocated to three groups by picking up 
sequentially one of the sealed opaque envelopes which contained group code inside. Each 
groups received different initial TBC of propofol for induction of anaesthesia: group I (n 
= 45) received TBC 2 Jlg/ml; group II (n = 45) TBC 3 J.lg/ml and group III (n = 45) TBC 
4 Jlg/ml respectively. In the OT, intravenous access and standard anaesthetic monitoring 
were recorded including bispectral (BIS) index monitor, noninvasive arterial blood 
pressure, electrocardiogram, pulse oximetry and capnography. 
Preoxygenation was given adequately for 5 minutes and subsequently slow bolus 
intravenous alfentanil 30 J.lg/kg was delivered. Immediately after that, patients were 
induced with TCI system of propofol with selected initial TBC that was earlier decided 
from randomization. TCI was administered by 'Terufusion' syringe pump TE-372 
TCIITIVA (Terumo®) incorporated with Diprifusor subsystem (Zeneca Ltd). Induction 
time was taken as the time from the start of propofol administration until successful loss 
of verbal contact within 3 minutes of achieving target blood concentration. If patients 
were still not successfully induced within 3 minutes, the induction was considered as fail 
5 
and TBC was immediately increased to 5 tJg/ml. After induction, the patients were 
paralyzed with intravenous rocuronium 0.6 mg/kg and subsequently intubated. Effect site 
concentration which was displayed on infusion pump was also recorded at successful 
induction. Systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial 
pressure (MAP) and heart rare (HR) were recorded at baseline before induction, 1 
minute, 3 minutes and 5 minutes after induction. Bispectral index (BIS) value was 
monitored to ensure adequate depth of anaesthesia. 
During maintenance of anaesthesia, TBC was adjusted between 1.5 to 6 tJg/ml in 
order to achieve adequate depth of anaesthesia based on BIS index value of 40-60. 
Oxygen was maintained with air mixture at Fi02 0.4 throughout surgery. Intravenous 
alfentanil was continuously infused at 30 tJg/kg/h. If it was necessary, alfentanil infusion 
would be increased every 5 J.lg/kg/h until the maximum of 60 J..lg/kg/h (0.5 tol.O 
J.1g/kg/min). Haemodynamic parameters were continuously recorded at 10 minutes 
interval until end of surgery. Additional doses of intravenous rocuronium were given 
about one third of the initial dose when it was necessary. 
Alfentanil infusion was stopped 10 minutes before the end of surgery. TBC was 
gradually reduced in about 15 minutes before the end of surgery until BIS index value 
between 60-70 and subsequently stopped 5 minutes before completed closure of surgical 
incision. When patients had spontaneous breathing, reversal was given using mixture of 
intravenous neostigmine 2.5 mg and intravenous atropine 1 mg. The patients were 
extubated when fully recovered and then observed in recovery room. 
For statistical analysis, SPSS software version 11.0 was used. Success rate of 
induction within 3 minutes was analyzed by using chi-squared test and multiple logistic 
6 
regression analysis. The results were expressed in percentage. Induction time was 
analyzed by one-way analysis of covariance (ANCOVA) test and results were expressed 
as estimated marginal mean. Haemodynamic changes were analyzed by using repeated 
measures analysis of variance (ANOVA). All results were expressed as mean ± SD. 
Effect site concentrations were analyzed by using analysis of variance (ANOV A) and 
results were expressed as mean± SD. A value of p < 0.05 was considered statistically 
significant. 
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RESULTS 
Demographic data was shown in Table 1. There were no significant differences in all 
demographic data between 3 groups except for sex data (p < 0.05). Group III had more 
female patients, 84.4% compared to the other groups, 57.8 %in group I and 60% in 
group II. Male patients were only 15.6% in group Ill, but 42.2% in group I and 40% in 
group II. 
Success rate of induction within 3 minutes was highest in group III, 91.1 %, 86.7 
% in group II and only 55.6 % in group I (Table 2). There were significant differences 
between three groups (p < 0.05). However from multivariate analysis using multiple 
logistic regression tests, comparing between each group, successful induction was only 
significant between group I and group III (p < 0.05) but was not significant between 
group II and group lll. 
Estimated marginal means and confidence interval of induction time were 7 4 
(60, 88) seconds in group I, 74 (63, 86) seconds in group II and 55(63, 88) seconds in 
group III as shown in Table 2. There were no significant differences between the three 
groups. 
Effect site concentrations at induction were 0.6 (0.3) J.lg/ml for group I, 0.9 (0.5) 
J.lg/ml for group II and 0.8 (0.3) J.lg/ml for group III (Table 2). There were significant 
differences in effect site concentrations at induction between the three groups (p < 0.05). 
However from multiple comparisons, the differences were only significant between 
group I and group II. 
Mean± SD of SBP, DBP, MAP and HR at baseline, 1 minute, 3 minutes and 5 
minutes after induction for the three groups are shown in Table 3. There were significant 
8 
changes of SBP, DBP, MAP and HR from baseline to 5 minutes after induction within 
each group (p < 0.05). However there were no significant differences between the three 
groups. 
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DISCUSSION 
Since it was introduced in 1996, most of the previous studies for TCI of propofol 
were done in United States and Europe. There were only a few studies found in the Asia 
region from the literature review. Short TG et al., from Chinese University of Hong Kong 
did a study in 1996 to evaluate the algorithm of White and Kenny for pharmacokinetic 
model of propofol for TCI and it was found to perform adequately in their population 7• Li 
YH eta/., did an assessment of predictive performance of a 'Diprifusor' TCI system in 
Chinese patients and they found that the accuracy of the 'Diprifusor' TCI system could 
be considered clinically acceptable8• 
From the previous studies of TCI, generally the recommended range of TBC for 
induction are between 4-8 Jlg/ml and for maintenance are between 3-6 Jlg/ml. For the 
initial induction TBC, 4 Jlg/ml was recommended in premedicated patients and 6 tJ.g/ml 
in unpremedicated patients4• Chaudri eta/. showed that propofol TBC of3, 4 and 5 tJ.g/ml 
could induce anaesthesia in 40 %, 15% and 90% respectively, in ASA I and II patients 
premedicated with termazepam9• Tzabar Y et al., studied the effect of co-induction with 
intravenous midazolam at the dose of 1, 2 and 4 mg respectively on the success rate of 
induction using TCI when TBC was maintained at 3 Jlg /mi. Success rate was only 45 % 
without midazolam whereas the other 3 groups were 70 %, 85 % and 95 % respectively 
which showed more successful induction with increasing dose of midazolam IO. 
Premedication was also associated with higher success rate of induction with an initial 
TBC of 4 flg /mi. In unpremedicated patient only 3 5 % of induction was successful 
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whereas success rate was up to 87 % of in premedicated patients with only oral 
diazepam 10 mg and 93 % when combined diazepam with intravenous alfentanil 10 
J.1g/kg4• In 40 patients who received premedication with diazepam 10 mg orally and were 
given IV alfentanil 7.5 J.lg/kg immediately before induction, 80 % was successfully 
induced at TBC of 4 J.lg/ml and 95 % at TBC 6 J.1g/ml 11 • Masago K et a/. from University 
of Tokyo studied the effect of IV fentanyl 2 J.lg/kg on success rate of induction with TBC 
of 3 f.lg/ml and showed success rate of 90 %12• However there was no previous study 
that used TBC of 2 f.lg/ml as an initial TBC for induction. 
In our study, we compared three groups ofTBC, 2, 3 and 4 J.lg/ml respectively for 
initial induction with all patients were standardized to receive oral midazolam 7.5 mg for 
premedication and IV alfentanil 30 J.Lg/kg as an initial analgesia before starting TCI. 
There was a significant difference in sex distribution between the three groups. However 
by using multivariate analysis, this factor would not affect the results of statistical 
analysis. The result showed that success rate of induction was 55.6% in TBC 2 J.lg/ml, 
86.7 % in TBC 3 J.lg/ml and 91.1 % in TBC 4 J.1g/ml. However a significant difference 
was only between TBC 4 J.lg/ml and 2 J.1g/ml. This result was consistent with previous 
one which showed that majority of patients were still successfully induced with TBC 4 
J.1g/ml. However TBC 3 J.1g/ml was almost comparable with TBC 4 J.lg/ml. Although there 
was no previous study comparing with TBC 2 J.lg/ml but our study showed with TBC as 
low as 2 JJg/ml, more than 50% of patients could still be successfully induced. TBC at 2 
J.lg/ml was previously proved to be a concentration that could actually achieved a sedative 
effect. Janzen et al. did a study to determine sedation levels reached by TCI in 30 
unpremedicated patients undergoing muscle biopsy under femoral nerve block. They 
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found that TBC of 2.1 f.J.g/ml was the EDSO of target propofol concentration for sedation 
at sedation levels 4 (responsive to physical stimulation only) 13• 
The optimal dose of alfentanil for providing complete attenuation of the 
cardiovascular and catecholamine response to tracheal intubation is 30 J..lg/ kg14• We used 
this result as a reference to start alfentanil at the dose of 30 J.lg/kg before induction using 
TCI. Alfentanil is known to have a synergistic pharmacokinetic and pharmacodynamic 
interaction with propofol5• When administered at a constant rate of 45 J..lg/kg/h, alfentanil 
reduces the mean infusion rate of propofol needed for maintenance of anaesthesia to 
about 5 mg/kg/h15• Similarly when the propofol TBC is 2, 4 or 6 J.lg/ml, the mean 
infusion rate of alfentanil required to maintain adequate anaesthesia is about 76, 30 or 18 
fJg/kg/h respectively5• Alfentanil increases propofol concentrations by up to 20 %, 
administered by TCI, when given in combination at concentrations of 40-80 ng/ml 
associated with moderate degrees of sedation16• In healthy male volunteers, alfentanil 
reduces both the distribution and clearance of propofol, thus increasing blood propofol 
concentrations17• Plasma alfentanil concentrations also have been shown to increase in 
the presence ofpropofol, administered by TCI16• This is due to inhibition of the oxidative 
metabolism of alfentanil by cytochrome P450 enzyme after administration of propofol, 
although this has only been described in vitro18• Synergism also has been demonstrated 
between propofol and midazolam when given as intravenous boluses for induction of 
anaesthesia. Short T G et al. reported that administration of midazolam 0.13 mg!kg 
reduced the ED50 ofpropofol by 52%7• 
Induction time of successful induction was 111, 116 and 103 seconds respectively 
at TBC 3 J.lg/ml, 4 f.J.g/ml and 5 f.!g/ml in patients who were premedicated with 
12 
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temazepam 20-30 mg9. Mean induction times were 78 seconds when patients received 
TBC of 4 J.!g/ml for induction after premedication with intravenous midazolam 0.03 
mg/kg and alfentanil IOJ.!g/kg19• At TBC of 4 J.!g/ml, induction time was 181 seconds 
without any premedications. When patients were premedicated with diazepam I 0 mg 
orally alone or in combination with alfentanil 1 0 J.!g/kg, mean induction time was 
significantly faster to 88 and 79 seconds respectively4• Servin F Setal. also reported that 
induction time was 90 seconds at TBC 4 J.!g/ml and 65 seconds at TBC 6 J.!g/ml when 
patients in both groups were premedicated with diazepam 10 mg orally and were given 
alfentanil 7.5 J.!g/kg before induction11 • In our study, patients were given higher dose of 
alfentanil at 30 J.lg/kg before induction and the results showed a faster induction time. 
Estimated marginal mean of induction time was 73.36 seconds in TBC 2 Jlg/ml, 74.12 
seconds in TBC 3 J.!g/ml and 55.25 seconds in TBC 4 J.!g/ml which showed no significant 
differences between the groups. 
Chaudri S et al. reported significant reductions in SBP and DBP at 3 min 
compared with baseline values within all the three groups, but there were no significant 
differences between the groups. The mean decreases in systolic arterial pressure ranged 
from 1 0-13 % which was improved if compared with induction by bolus doses and with 
continuous infusion9• At TBC 3 J.!g/ml, there were no significant differences of SBP, 
DBP and HR changes at baseline or at 3 min whether it was co-induced with 0, 1, 2 or 4 
mg of IV midazolam. However there were reductions if compared between baseline and 
at 3 min ro. These results were comparable with our study which showed no significant 
differences in SBP, DBP, MAP or HR between the groups at baseline, 1 min, 3 min or 5 
min. However the changes within the group were significant if compared to the baseline 
13 
value but all values were still within acceptable reading. Overall all estimated marginal 
means of SBP are > 90 mmHg, DBP > 50 mmHg, MAP > 60 mmHg and HR > 50 either 
at 1, 3 or 5 minutes. 
The TBC of propofol only relates to the depth of anaesthesia when there is 
equilibrium between the plasma and effect site. The effect site concentration during 
infusion can be calculated using the equilibrium rate constant (keo ). If a constant plasma 
concentration is maintained, then the time for the effect site concentration to reach 50 % 
of the plasma concentration is given by 0.693/keo. Conway DH et al. studied the influence 
of co-induction with remifentanil and midazolam on effect site propofol requirements at 
induction of anaesthesia The effect site concentration of propofol alone was 2.l9J.Lg/ml. 
This was reduced to 1.55 Jlg/ml during co-induction with target-controlled remifentanil 
(3ng/ml) and further reduced to 0.64 Jlg/ml with midazolam premedication (0.03mglkg) 
20
• This is comparable with our study. Starting TCI at TBC 2, 3 or 4 Jlg/ml with co-
induction using alfentanil 30 Jlg/kg and oral midazolam 7.5 mg premedication, mean total 
effect site concentration at induction was 0. 77 ± 0.40 J.Lg/ml. There was no big mean 
difference margin even though effect site concentration at TBC 2 (0.60 ± 0.31) was 
significantly difference from at TBC 3 (0.86 ± 0.4 7). Michel MRF et al. did a study to 
compare TCI device controlled the plasma concentration with TCI device to control the 
effect site concentration. They found that targeting the effect site concentration shortened 
the time to loss of consciousness compared with the targeting plasma concentration 
without causing hypotension21 • In future, with some modification in pharmacokinetic 
parameters, TCI device to control the effect site concentration will become popular in 
clinical practice. 
14 
~"--C•~---· -.-..-::-- =======:::========::-=-:----=----------------··------
In conclusion, this study shows that TBC at 3 J.lg/ml is comparable with 
recommended initial TBC at 4 J.1g/ml for induction of anaesthesia using TCI technique 
without significant differences in success rate of induction, induction time, effect site 
concentration and haemodynamic changes. Although TBC at 2 J.lg/ml shows an 
encouraging result with 55.6% of successful induction, it is not recommended if rapid 
and definite successful induction is required. Therefore in our population, it is 
recommended to start induction using TCI technique of propofol by TBC at 3 JJ.g/ml and 
then to titrate accordingly when it is necessary. 
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Table 1. Demographic data. Age and weight are given as mean (SD). All other 
categorical data are given in number of patients (% ). 
Initial TBC (pg/ml) 
No. of patients ;n 
Age; years 
Body weight ; kg 
*Sex; n (%) 
Male 
Female 
Race; n (%) 
Malay 
Chinese 
Indian 
Others 
ASA; n(%) 
I 
II 
Type of surgery ; n (%) 
Gynaecology 
Surgery 
Orthopaedic 
Others 
TBC = target blood concentration 
* p < 0.05 
GROUP I 
2 
45 
34.0 (11.6) 
61.8 (14.2) 
19 (42.2%) 
26 (57.8%) 
40 (88.9%) 
3 (6.7%) 
1 (2.2%) 
1 (2.2%) 
36 (80.0%) 
9 (20.0%) 
9 (20.0%) 
19 (42.2%) 
16 (35.6%) 
1 (2.2%) 
GROUP II 
3 
45 
33.8 (11.4) 
59.7(11.3) 
18 (40.0%) 
27 (60.0%) 
40 (88.9%) 
4 (8.9%) 
0 (0.0%) 
1 (2.2%) 
35 (77.8%) 
10 (22.2%) 
11 (24.4%) 
19 (42.2%) 
13 (28.9%) 
2 (4.4%) 
GROUP III 
4 
45 
38.2 (10.4) 
59.8 (11.8) 
7 (15.6%) 
38 (84.4%) 
41 (91.1%) 
4 (8.9%) 
0 (0.0%) 
0 (0.0%) 
31 (68.9%) 
14 (31.1%) 
18 (40.0%) 
21 (46.7%) 
6(13.3%) 
0 (0.0%) 
Table 2. Induction characteristics. Successful induction is expressed as number of 
patients (% ), induction time as mean (confidence interval) and effect site as mean (SD). 
Initial TBC 
(pglml) 
GROUP I 
2 
GROUP II GROUP III 
3 4 
Successful induction; n (%) 25 (55.6%)* 39 (86.7%) 41 (91.1%)* 
Induction time; s 74(60,88) 74(63,86) 55(63,86) 
Effect site concentration at induction; 0.6 (0.3)* 0.9 (0.5)* 0.8 (0.3) 
Jlg/ml 
* p < 0.05 
Table 3. Mean of haemodynamic data (SD) at different time interval 
Initial TBC 
(p.g/ml) 
SBP (mmHg) 
Baseline 
1 min 
3 min 
5min 
DBP(mmHg) 
Baseline 
I min 
3min 
5 min 
MAP(mmHg) 
Baseline 
1 min 
3 min 
5min 
HR (beats/min) 
Baseline 
1 min 
3 min 
5 min 
GROUP I 
2 
125 (16) 
103(12) 
99(14) 
99(17) 
71 (11) 
60 (12) 
56(13) 
54(10) 
89(11) 
75(10) 
71(13) 
70(14) 
77(17) 
69(20) 
68(18) 
72(19) 
GROUP II 
3 
128(18) 
105(18) 
102(18) 
100(16) 
69 (10) 
54 (9) 
55 (10) 
53 (10) 
89(11) 
71(11) 
72(13) 
69(12) 
79(16) 
72(13) 
72(15) 
81(16) 
GROUP III 
4 
131(19) 
102(16) 
100(17) 
97(16) 
75 (11) 
57 (10) 
58(13) 
56(11) 
95(12) 
73(12) 
73(15) 
71(12) 
78(17) 
69(15) 
69(14) 
72 (16) 
SBP =Systolic blood pressure; DBP =Diastolic blood pressure; MAP= Mean arterial 
pressure; HR =Heart rate. No significant differences between the three groups. 
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ABSTRAK 
Objektif: 
Untuk membandingkan kadar kejayaan dalam menghasilkan permulaan kesan bius 
(induksi) dalam masa 3 minit, jangkamasa yang diambil untuk induksi dan perubahan-
perubahan hemodinamik diantara tiga sasaran kepekatan dalam darah (SKD) bagi propofol 
yang berbeza di dalam populasi rakyat Malaysia yang didominasi oleh keturunan Melayu. 
Tatacara: 
Di dalam kajian prospektif ini, 135 pesakit dalam klasifikasi ASA I dan II, berumur di 
antara 18-55 tahun dan menjalani sebarang pembedahan yang dijadualkan, telah 
dibahagikan secara rawak kepada 3 kumpulan. Kumpulan I menerima SKD permulaan 2 
J.lg/ml (n = 45), kumpulan II menerima permulaan SKD 3 J.lg/ml (n = 45) dan kumpulan III 
menerima pennulaan SKD 4 J.lg/ml (n = 45) untuk menghasilkan induksi pembiusan. 
Semua pesakit diberikan ubat midazolam 7.5 mg secara oral di dalam wad 30 minit 
sebelum permulaan bius dan diberi alfentanil 30 J.lg/kg sebagai ubat penahan sakit secara 
suntikan melalui salur darah (intravena). Jangkamasa yang diambil untuk induksi bius 
dikira daripada permulaan aliran (infusi) ubat sehingga tiada lagi tindakbalas lisan dan 
pembiusan dikira berjaya jika ketiadaan tindakbalas lisan dicapai dalam masa 3 minit 
daripada permulaan infusi. Parameter-parameter hemodinamik (tekanan darah sistolik 
' 
tekanan darah diastolik, tekanan darah 'mean' dan kadar denyutan jantung) direkodkan 
pada bacaan dasar, 1 minit, 3 minit dan 5 minit selepas induksi. Pesakit seterusnya 
X 
dilumpuhkan dengan dengan suntikan intravena rocuronium 0.6 mg/kg dan diintubasikan. 
Pengekalan kesan bius diteruskan dengan pembiusan intravena secara keseluruhan 
menggunakan kaedah infusi kawalan sasaran (IKS) propofol pada SKD diantara 1.5-6 
J.tg/ml dan infusi alfentanil 30-60 Jlg/ kg/ h. 
Keputusan: 
Kadar kejayaan induksi ialah 55.6% bagi SKD 2 Jlg/ml, 86.7% bagi SKD 3 Jlg/ml and 
91.1 % bagi SKD 4 Jlg/ml di mana ia menunjukkan perbezaan yang signifikan (bererti) 
diantara ketiga-tiga kumpulan (p=O.OOO). Walau bagaimanapun berdasarkan analisa 
'multivariate' menggunakan kaedah regrasi logistik, kadar kejayaan induksi hanya 
menunjukkan perbezaan yang signifikan diantara SKD 2 Jlg/ml dan SKD 4 Jlg/ml (p = 
0.001) tetapi tidak signifikan diantara SKD 3 J.lg/ml dan SKD 4 J.lg/ml (p = 0.898). 
Anggaran 'marginal means' dan konfidens interval 95% bagi jangkamasa induksi adalah 
73.63 (59.08, 88.18) saat bagi SKD 2 Jlg/ml, 74.12 (62.58, 85.65) saat bagi SKD 3 Jlg/ml 
and 55.25 (40.76, 69.75) saat bagi SKD 4 Jlg/ml yang mana ia tidak menunjukkan 
perbezaan yang signifikan (p = 0.101). Terdapat perbezaan perubahan yang signifikan di 
dalam semua parameter hemodinamik tetapi tiada perbezaan yang signifikan jika 
dibandingkan diantara ketiga-tiga kumpulan. 
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Kesimpulan: 
SKD 3 J.lg/ml adalah setara jika dibandingkan dengan SKD 4 J.lg/ml untuk induksi 
pembiusan dengan tiada perbezaan yang signifikan dari segi kadar kejayaan induksi, 
jangkamasa induksi dan perubahan-perubahan hemodinamik. SKD 2 J.lg/ml tidak 
disarankan untuk permulaan induksi. 
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ABSTRACT 
Objectives: 
To compare success rate of induction within 3 minutes, induction time and haemodynamic 
changes between three different target blood concentrations (TBC) of propofol m a 
predominantly Malay Malaysian population. 
Methodology: 
In this prospective study, 135 ASA I and II patients in age between 18-55 years old and 
underwent any elective surgery were randomized into 3 groups. Group I received initial 
TBC of 2 J.Lg/ml ( n = 45 ), group II received initial TBC of 3 J.Lg/ml ( n = 45 ) and group 
m received initial TBC of 4 J.Lg/ml ( n = 45 ) for induction of anaesthesia. All patients 
were premedicated with oral midazolam 7.5 mg in the ward 30 minutes before induction 
and were given N alfentanil 30 J.Lg/kg bolus as analgesia. Induction time was measured 
from starting of infusion until loss of verbal contact and induction was considered 
successful if loss of verbal contact was achieved within 3 minutes from starting of 
infusion. Haemodynamic parameters (SBP, DBP, MAP and HR) were recorded at baseline 
' 
1 minutes, 3 minutes and 5 minutes after induction. Patients were subsequently paralyzed 
with N rocuronium 0.6 mglkg and intubated. Maintenance of anaesthesia was continued 
with total intravenous anaesthesia using TCI of propofol at TBC of 1.5-6 f.lg/ml and 
alfentanil infusion at 30-60 J.Lg/kg/h. 
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Results: 
Success rate of induction was 55.6% in TBC 2 Jlg/ml, 86.7% in TBC 3 Jlg/ml and 91.1 % 
in TBC 4 J.lg/ml, which showed significant difference between 3 groups (p = 0.000). 
However from multivariate analysis using logistic regression method, success rate were 
only significantly difference between TBC 2 J.Lg/ml and TBC 4 Jlg/ml (p = 0.001) but were 
not significantly difference between TBC 3 Jlg/ml and TBC 4 Jlg/ml (p = 0.898). Estimated 
marginal means and 95% confidence interval of induction time were 73.63 (59.08, 88.18) s 
in TBC 2 J.lg/ml, 74.12 (62.58, 85.65) sin TBC 3 J.lg/ml and 55.25 (40.76, 69.75) sin TBC 
4 Jlg/ml which showed no significant difference (p = 0.101). There were significant 
changes within all haemodynamic parameters but no significant differences between the 
groups. 
Conclusions: 
TBC 3 J.lg/ml was comparable with TBC 4 J.lg/ml for induction of anaesthesia with no 
significant differences in success rate of induction, induction time or haemodynamic 
changes. TBC 2 Jlg/ml is not recommended for initial induction. 
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CHAPTER 1: INTRODUCTION 
Propofol (Diprivan) was introduced in 1986 as an intravenous anaesthetic agent for the 
induction and maintenance of general anaesthesia. Widespread clinical experience with 
propofol has established the benefits relating to the quality of control of anaesthesia and 
the quality of recovery. Onset and offset of anaesthetic effects are rapid and reliable. 
Propofol offers rapid emergence, low incidence of postoperative nausea and vomiting 
(PONV) and a potential reduction in time to discharge. Total intravenous anaesthesia 
(TIV A) based on propofol has the general advantage of avoiding occupational exposure to 
inhalational agents. 
Manual control of propofol infusion for maintenance of anaesthesia is sometimes 
viewed as "not as easy as" using vaporizer with an inhalational agent. There is, therefore, a 
general need for a more convenient method for infusing intravenous agent. Target 
controlled infusion (TCI) systems have been developed to provide improved convenience 
and control during intravenous anaesthesia. The basic principle is that the anaesthetist sets 
and adjusts the target blood concentration and depth of anaesthesia as required on clinical 
grounds. Infusion rates are altered automatically according to validated phannacokinetic 
model. 'Diprifusor' (TCI software/ subsystem/ system) for propofol is such a development. 
'Diprifusor' is the first commercially available TCI system and is incorporated in syringe 
pumps from major manufacturer. 
TCI has several potential benefits over manually controlled infusion (MCI) 
technique. Benefits can be considered mainly in terms of converuence in use and control of 
anaesthesia. In term of convenience in use, it is simple to operate and easy to titrate the 
level of anaesthesia. It also displays calculated blood or plasma concentrations and 
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provides continuous process from induction through to maintenance. In term of control of 
anaesthesia, it has a good control of depth of anaesthesia and can also provide a stable 
anaesthesia. Furthermore it· can improve cardiovascular and respiratory parameters 
stability. 
From the previous studies, the recommended range for induction is 4-8 J.Lg/ml and 
for maintenance is 3-6 J.Lg/ml. For the initial induction target blood concentration (TBC), 4 
IJ.g/ml is recommended in premedicated patients and 6~g/ml in unpremedicated patients. 
Most of the previous studies for the propofol TCI were done in US and Europe. There are 
only a few studies found in the Asia region from the literature review. The aim of this 
study is to determine whether the recommended initial target blood concentration from the 
Western studies is also applicable to our local population. As for other anaesthetic agents, 
there are wide interindividual pharmacokinetic and pharmacodynamic variability in 
propofol requirement. Therefore there are high possibilities that our target blood 
concentrations requirement of propofol in either induction or maintenance are lower than 
recommendation if we base on our relatively smaller physical built, body weight, race and 
also genetic differences. 
1.1. Objectives 
1. To compare success rate of induction within 3 JJ?.inutes of achieving the target 
concentration between three different target blood concentrations 
2. To compare induction time of successful induction between three different 
target blood concentrations. 
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3. To compare haemodynamic changes between the three different target blood 
concentrations. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Propofol 
2.1.1 Chemical structure 
Propofol is a new intravenous anaesthetic agent chemically unrelated to barbiturate, 
steroids, imidazole, or eugenol agents. It is one of a series of alkyl phenols, found to have 
anaesthetic properties in animals. The structure of propofol, 2, 6-diisoprophylphenol is 
shown in figure 2.1. 
Figure 2.1: Chemical Structure of Propofol 
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2.1.2 Preparation 
Propofol was originally formulated as a 1 % solution in 16 % polyoxyethylated castor oil 
(Cremophor EL). This preparation was associated with severe pain on injection and 
anaphylactoid reactions. Since 1982, propofol has been reformulated in a concentration of 
10 mg/ml in fat emulsion. The present formulation consists of 1 percent (wt/vol) propofol, 
10 percent soybean oil (long-chain triglycerides ), 2.25 percent glycerol, and 1.2 percent 
purified egg phosphatide. It has a pH of 7 and appears as a slightly viscous, milky white 
substance. Propofol is available as a I percent solution in 20-ml clear glass ampules and 
50-ml vials. It is stable at room temperature and is not light-sensitive. If a dilute solution of 
propofol is required, it is compatible with 5 percent dextrose in water. 
The formulation has not been associated with known anaphylactoid reactions, but 
moderate to severe pain on injection is still a problem in 32%-67% of patients. Previous 
studies have shown that high concentrations of free propofol in the aqueous phase of 
emulsion are associated with pain on injection (Fragen RJ, 1988). 
There is a new formulation of propofol in a 10 % fat emulsion consisting of long-
chain triglycerides and medium-chain triglycerides which has infrequent incidence of 
moderate or severe pain. Doenicke A Wet a/. (1997) showed that there was a significant 
reduction in reported severe or moderate pain on injection after propofol 1% in the new 
formulation (9 %) than after standard formulation (59%). 
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2.1.3 Pharmacokinetics 
The phannacokinetics of propofol following a wide range of doses as well as following 
continuous infusions have been evaluated by numerous investigators and have been 
described by both two- and three-compartment models. Following a single bolus injection, 
whole blood propofol levels decrease very rapidly as a result of both redistribution and 
elimination. The initial distribution half-life of propofol is 2 to 8 minutes (Simons P J et a!, 
1985). In studies using a two-compartment model, the elimination half-life has varied from 
1.0 to 3 hours (Shafer A eta/, 1988). Studies using a three-compartment model have given 
initial and slow distribution half-lives of 1 to 8 minutes and 30 to 70 minutes and an 
elimination half-life of 4 to 23.5 hours (Bailie GRetal, 1992).This longer elimination half-
life is indicative of a deep compartment with limited perfusion, which results in a slow 
return of propofol back to the central compartment. Owing to the very rapid clearance of 
propofol from the central compartment, the slow retwn of propofol from this deep 
compartment contributes little to the initial rapid decrease in propofol concentrations. The 
context-sensitive half-time for propofol for infusions of up to 8 hours is less than 40 
minutes (Hughes MA et al, 1992). As the required decrease in concentration for awakening 
following anesthesia or sedation with propofol is generally less than 50 percent, recovery 
from propofol will remain rapid even following prolonged infusions. The volume of 
distribution of the central compartment has. been calculated ·as 20 to 40 L and the volume 
of distribution at steady state as 150 to 700 L. The clearance of propofol is extremely high 
at 1.5 to 2.2 L/min. This exceeds hepatic blood flow, and extrahepatic metabolism has 
been demonstrated. The keo (the first order rate constant for equilibration of the effect site 
with plasma concentration) for propofol is 0.291 min-1 and the tl/2 keo is 2.4 minutes 
6 
based on suppression of the EEG. The time to peak effect is 92 seconds (Dyck JB eta!, 
1991). 
The pharmacokinetics of propofol may be altered by a variety of factors (e.g., gender, 
weight, pre-existing disease, age, and concomitant medication). Women have a higher 
volume of distribution and higher clearance rates, but the elimination half-life is similar for 
males and females (Kay NH et a!, 1986). The elderly have decreased clearance rates but a 
smaller central compartment volume (Kirkpatrick T et al, 1988). Children have a larger 
central compartment volume (50 percent) and a more rapid clearance (25 percent) (Marsh 
B et a/, 1991 ). Hepatic disease appears to result in a larger steady state and central 
compartment volumes; clearance is unchanged but the elimination half-life is slightly 
prolonged (Servin F et a!, 1987). The effect of fentanyl administration on propofol 
phannacokinetic parameters is controversial. Some studies suggest that fentanyl may 
reduce both intercompartmental and total body clearance rates as well as volumes of 
distribution (Benoni G et a/, 1990).ln a separate study fentanyl did not alter propofol 
pharmacokinetics following a single dose of both drugs (Gill SS et al, 1990). In in vitro 
studies on human hepatocytes, propofol inhibited in a dose-dependent manner the 
enzymatic· degradation of both sufentanil and alfentanil (Janicki PK et al, 1992). Propofol 
kinetics is unaltered by renal disease (Marcos WE et al, 1985). Four published 
pharmacokinetic studies have been performed in children. yariations between these four 
studies may be attributable to differences in sampling interval (which influences the size of 
central compartment, small numbers of patients, the effects of adjunctive anaesthetic drugs, 
and the use of different modeling techniques (Fisher DM, 1994). Despite these intrastudy 
differences, all four studies demonstrated that the volume of propofol, s central 
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compartment is larger (on a per kg body weight basis) in children than in adults. The 
clearance rate of propofol is also higher in children. Therefore, children will require a 
larger induction dose and increased maintenance infusion rate (per kilogram body weight) 
than adults (Hanallah RS, 1992). As in adults, other factors (e.g., the infusion duration) 
also influence the effect ofpropofol on recovery in children (Fisher DM, 1994). 
2.1.4 Metabolism 
Propofol is rapidly metabolized in the liver by conjugation to glucuronide and sulfate to 
produce water-soluble compounds, which are excreted by the kidneys. Less than I % 
propofol is excreted unchanged in urine, and only 2 % is excreted in feces (Simons P J et 
al, 1985). The metabolites of propofol are thought not to be active. Because clearance of 
propofol exceeds hepatic blood flow, extrahepatic metabolism or extrarenal elimination 
has been suggested. Extrahepatic metabolism has been confirmed during the anhepatic 
phase of patients receiving a transplanted liver (Veroli P et a/, 1992) .The lungs do not 
seem to be the site of this extrahepatic metabolism. 
2.1.5 Pharmacodynamics 
2.1.5.1 Effects on the Central Nervous System 
Propofol is primarily a hypnotic. The exact mechanism of its action has not yet been fully 
elucidated; however, evidence suggests that it acts by enhancing the function of the 
GABA-activated chloride channel. Although propofol acts via the GABA receptor, its 
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action is pressure-reversible, and it adheres to the correlation exhibited by other general 
anesthetics between anesthetic potency and octanollwater distribution coefficient (Tonner 
PH et a/, 1992). Unlike barbiturates, propofol is not antianalgesic. The onset of hypnosis 
following doses of 2.5 mglkg is rapid (one ann-brain circulation). The ED 50 of propofol is 
1 to 1.5 mglkg following a bolus. The duration of hypnosis is dose-dependent, being 5 to 
10 minutes following 2 to 2.5 mg/kg (Major E et al, 1981 ). Age markedly affects the ED95 
induction dose of propofol, being highest at ages less than 2 (ED95 2.88 mglkg) and 
decreasing with increasing age (Aun CST et al, 1992). At subhypnotic doses propofol will 
provide sedation and amnesia (Mackenzie N et a!, 1987; Wilson E et al, 1988). Propofol 
infusions of at least 2 mg/kg/h were necessary to provide amnesia in unstimulated 
volunteers. Awareness during surgery at higher infusion rates bas been reported (Zacny JP 
et al, 1992). During surgical procedures very high infusion rates may be necessary to 
prevent awareness if propofol is used as the sole anesthetic. Propofol alters mood 
following short surgical procedures to a lesser extent than thiopental. Propofol also tends 
to produce a general state of well-being. Hallucinations, sexual fantasies, and opisthotonos 
have been reported following propofol administration. 
The effect of propofol on the EEG as assessed after 2.5 mg/kg followed by an infusion 
demonstrates an initial increase in a-rhythm followed by shift to d and u frequency. High 
infusion rates produce burst suppression (Hazeau C et al,. 1997). EEG power analysis 
indicates that amplitude increases after induction but is thereafter unaltered at propofol 
blood concentrations of 3 to 8 mg/ml. At propofol concentrations greater than 8 mg/ml, 
amplitude markedly decreases, with periods of burst suppression (Yate PM et ai, 1986). 
There is a strong correlation between the logarithm of blood concentration of propofol and 
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the percentage of d activity content, and there is an inverse correlation with percentage of b 
activity content. The effect of propofol on epileptogenic EEG activity is controversial. 
Initial studies in mice indicate that propofol neither induced convulsions nor provided 
anticonvulsant activity. Several more recent reports have shown in a variety of models a 
direct anticonvulsant effect of propofol, which is dose-dependent (Heavner JE et a/, 1992). 
In a few reports propofol has been used to treat epileptic seizures (Wood PR et al, 1988; 
Chilvers CR et al, 1992). Propofol also results in a shorter duration of motor and EEG 
seizure activity following electroconvulsive therapy as compared with methohexital 
(Dwyer R eta/, 1988). Interestingly, propofol has been associated with grand mal seizures 
and has been used for cortical mapping of epileptogenic foci (Hodkinson BP et a/, 1987). 
More importantly, there have been several reports of convulsions following propofol 
administration that have occurred several {up to 6) days following anesthesia. Although the 
majority of these patients had a history of previous convulsions, a few did not. The 
incidence of this adverse effect is rare (approximately 1 in 50,000 administrations). There 
have also recently been reports of tolerance developing to propofol following either repeat 
anesthetics or prolonged infusions (days) (Boyle WA et al, 1990).There have not been 
reports of acute tolerance during a single anesthetic. In addition to tolerance, addiction to 
propofol has been reported. Propofol produces a decrease in amplitude of the early 
components of somatosensory evoked potentials as well as ~ small nonsignificant increase 
in latency of the P40 and N50 components (Maurette P et al, 1988). Like other 
intravenous anesthetics, propofol does not alter brain stem auditory evoked 
potentials. There is, however a dose-dependent prolongation of latency and a decrease in 
amplitude of cortical middle latency auditory potentials, which are concentration-
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dependent (Savoia Get al, 1988). Propofol will decrease ICP in patients with either normal 
or elevated ICP. In patients with normal ICP, the decrease in ICP (±30 percent) is 
associated with a small decrease in cerebral perfusion pressure (±1 0 percent) (Ravussin P 
et al, 1988). The addition of small doses of fentanyl and of supplemental doses of propofol 
ablates the rise of ICP secondary to endotracheal intubation. Normal cerebral reactivity to 
carbon dioxide and autoregulation are maintained during a propofol infusion. In patients 
with elevated ICP, the decrease in ICP (30 to 50 percent) is associated with significant 
decreases in cerebral perfusion pressure and therefore may not be beneficial. Propofol 
reduces C:MR.02 to 36 percent (Stephan H et al, 1987). With a background of 0.5 percent 
enflurane, propofol still reduces CMR02 by 18 percent while lactate and glucose 
metabolism remain unchanged (V andesteene A eta/, 1988). Propofol administered to burst 
suppression results in significantly better neurologic outcome and less brain tissue injury in 
an incomplete ischemia model in rats, as compared with fentanyl. Propofol will also 
provide cerebral protective effects following an acute ischemic insult to the same degree as 
either halothane or thiopental (Gelb A Wet a/, 1993). Propofol acutely reduces intraocular 
pressure by 30 to 40 percent. As compared with thiopental, propofol produces a greater 
decrease in intraocular pressure, and following a small second dose it is more effective in 
preventing a rise in intraocular pressure secondary to succinylcholine and endotracheal 
intubation (Mirakhur RK. et ai, 1997). 
The propofol Cp50 for loss of response to verbal command is 3.5 mg/ml (Vuyk Jet 
al, 1992). The propofol Cp50 (arterial whole blood concentration) to prevent movement on 
skin incision is 16 mg/ml. This is markedly reduced by increasing concentrations of 
fentanyl (Smith C eta I, I 992). The propofol Cp50 for skin incision when combined with 
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benzodiazepine premedication (lorazepam I to 2 mg) and 66 percent nitrous oxide is 2.5 
mg/ml (venous) (Turtle MJ et a I, 1997). Thls concentration is reduced to 1. 7 mg/ml when 
morphine (0.15 mg/kg) rather than Iorazepam is used for premedication (Spelina KR et al, 
1986). The concentration of propofol (when combined with 66 percent nitrous oxide) 
required during minor surgery varies from 1.5 to 4.5 mg/ml (Schuttler J et a/, 1985) and 
that for major surgery varies from 2.5 to 6 mg/ml (Sanderson JH et a!, 1988). Awakening 
usually occurs below a concentration of 1.6 mg/ml and orientation below I .2 mg/ml. Age 
affects the propofol concentration required to provide adequate anesthesia. 
2.1.5.2 Effects on the Respiratory System 
Propofol affects the respiratory system in a manner qualitatively similar to the action of 
barbiturates. Apnea occurs after an induction dose of propofol. The incidence and duration 
of apnea appear dependent on dose, speed of injection, and concomitant premedication. An 
induction dose of propofol results in a 25 to 30 percent incidence of apnea (Sanderson JH 
et al, 1988; Taylor MB et a/, 1986). The apnea occurring with propofol however, may be 
prolonged to more than 30 seconds. The incidence of prolonged apnea (longer than 30 
seconds) is further increased by addition of an opiate, either as a premedication or just 
prior to induction( Sanderson JH eta!, 1988), and is greater. with propofol than with other 
commonly used intravenous induction agents (Gold MI et al, 1987). The onset of apnea is 
usually preceded by marked tidal volume reduction and tachypnea (Goodman NW et a/, 
1987). Following a 2.5 mg/kg induction dose of propofol, respiratory rate is significantly 
decreased for 2 minutes (Taylor MB et al, 1986), and minute volume is significantly 
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reduced for up to 4 minutes, ~hich indicates a more prolonged effect of propofol on tidal 
volume than on respiratory rate. 
A maintenance infusion of propofol (100 mg/kg/min) results in a 40 percent decrease in 
tidal volume and a 20 percent increase in respiratory frequency, with an unpredictable 
change in minute ventilation. Doubling the infusion rate from 1 00 to 200 mglkg/min 
causes a further moderate decrease in tidal volume ( 455 to 380 ml) but no change in 
respiratory frequency. The ventilatory response to carbon dioxide is also decreased during 
a maintenance infusion of propofol. At 1 00 mg/kg/min there is a 58 percent reduction in 
the slope of the carbon dioxide response curve (Goodman NW et a/, 1987). Propofol 1.5 to 
2.5 mg/kg results in an acute (13 to 22 percent) rise in PaC02 and a decrease in pH. Pa02 
does not change significantly (Aun C et al, 1984). During a maintenance infusion of 
propofol (54 mg!kg/min) PaC02 is moderately increased from 39 to 52 mmHg (Coates DP 
et a/, 1987). Doubling this infusion rate does not result in a further increase in PaC02. 
Propofol (50 to 120 mg/kg/min) also depresses the ventilatory response to hypoxia (Blouin 
RT et a/, 1992). Propofol induces bronchodilation in patients with chronic obstructive 
pulmonary disease (Conti Get al, 1993). Propofol, however, does not appear to provide as 
effective bronchodilating properties as halothane (Mehr EH eta/, 1992). 
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observation that subhypnotic doses of propofol fail to increase plasma prolactin 
concentrations (Borgeat A et a/, 1997). A rapid and distinct increase in plasma prolactin 
concentrations is characteristic of drugs that block the dopaminergic system. The 
antiemetic effect of propofol is not due to the intralipid emulsion in the formulation (Gan 
TJ et al, 1997). 
Propofol at subhypnotic doses has also been reported to relieve cholestatic pruritus, 
as well as pruritus induced by spinal opiates (Borgeat A et al, 1992). The mechanism of 
the antipruritic effect may be related to the drug's ability to depress spinal cord activity. In 
this regard, there is evidence that intrathecal opioids produce pruritus by segmental 
excitation within the spinal cord. 
Propofol possesses antiepileptic properties, presumably reflecting GABA-mediated 
presynaptic and postsynaptic inhibition. In this regard, propofol in doses of> I mg/kg IV 
decreases seizure duration 35% to 45% in patients undergoing electroconvulsive therapy 
(A vramov rvtN et a/, 1995). The incidence of excitatory movements and associated 
electroencephalogram (EEG) changes are low after the administration of propofol (Reddy 
RV et al, 1993). Propofol doe~ not produce seizure activity on the EEG when administered 
to patients with epilepsy, including those undergoing cortical resection (Cheng MA et al, 
1996; Ebrahim ZY et al, 1994; Samra SK eta!, 1995). 
Propofol has potent antioxidant properties that rese~ble those of the endogenous 
antioxidant vitamin E (Murphy PG et a/, 1992). A neuroprotective effect of propofol may 
be at least partially related to the antioxidant potential of propofol' s phenol ring structure. 
For example, propofol reacts with lipid peroxyl radicals and thus inhibits lipid peroxidation 
by forming relatively stable propofol phenoxy! radicals. In addition, propofol also 
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scavenges peroxynitrite, which is one of the most potent reactive metabolites for the 
initiation of lipid peroxidation. Because peroxynitrite is a potent bactericidal agent, it is 
likely that the peroxynitrite-scavenging activity of propofol contributes to this anesthetic's 
known ability to suppress phagocytosis (Krumholz W et al, 1994). Conversely, propofol 
might be beneficial in disease states, such as acute lung injury, in which peroxynitrite 
formation is thought to play an important role (Kooy NW eta/, 1995). 
2.1.6 Clinical uses 
2.1.6.1 Induction and Maintenance of Anesthesia 
Propofol is suitable for both the induction and maintenance of anesthesia. The induction 
dose varies from 1.0 to 2.5 mg/kg and the ED95 in unpremedicated adult patients is 2.25 to 
2.5 mg/kg (Cummings GC et al, 1984). Premedication with an opiate and or a 
benzodiazepine tends to markedly reduce the induction dose (Briggs LP et al, 1985) 
Increasing age also reduces the dose of propofol required to induce anesthesia (Dundee JW 
et al, 1986). A dose of 1 mg/kg (with premedication) to 1. 75 mg/kg (without 
premedication) is recommended for inducing anesthesia in patients over 60 years of age 
(Steib A et al, 1988).The ED95 (2.0 to 3.0 mg/kg) for induction is increased in children, 
primarily because of pharmacokinetic differences (Purcell-Jo~es G eta!, 1987). 
Propofol, when used for induction of anesthesia in shorter procedures, results In a 
significantly quicker recovery and earlier return of psychomotor function as compared with 
thiopental or methohexital, irrespective of the agent used for maintenance of anesthesia 
(Heath PJ et al, 1988; Mackenzie N et a!, 1985). The incidence of nausea and vomiting 
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when propofol is used for induction is also markedly less than following the other 
intravenous induction agents, probably because of the antiemetic properties of propofol. 
Propofol, because of its phannacokinetics, provides a rapid recovery and is thus superior to 
barbiturates for maintenance of anesthesia (Mackenzie N et a/, 1995), and it appears equal 
to enflurane and isoflurane (Doze VA et al, 1988; Glass P et a!, 1988). Recovery from 
desflurane is slightly more rapid than recovery from -propofol (Van Hemelrijck J et a/, 
1991). Propofol can be given as intermittent boluses or as a continuous infusion for 
maintenance. Following a satisfactory induction dose, a bolus of 10 to 40 mg is needed 
every few minutes to maintain anesthesia. As these doses need to be given frequently, it is 
more suitable to administer propofol as a continuous infusion. 
Several infusion schemes have been used to achieve adequate plasma concentrations of 
propofol (Roberts FL et a/, 1988). Following an induction dose, an infusion of I 00 to 200 
mg/kg/min is usually needed. The infusion rate is then titrated to individual requirements 
and the surgical stimulus. Morphine, fentanyl, or alfentanil when combined with propofol 
reduces its required infusion rate and concentration (Thomas VL et al, 1988). For 
maintenance propofol has been used as a single mixture with alfentanil, containing 1 mg 
alfentanil (2 ml) to 400 mg propofol ( 40 ml). When this mixture· was administered at 
infusion rates commonly used for propofol (i.e., 166 mg/kg/min for 10 minutes, 133 
mg/kg/min for 10 minutes, and 100 mg/kg/min thereafter), it .Provided an outcome equal to 
that obtained by using the two drugs as separate infusions (Taylor IN et al, 1992). 
Increasing age is associated with a decrease in propofol infusion requirements (Hilton pet 
al, 1986; Schuttler J et a/, 1992), which are higher in children and infants. The blood levels 
of propofol alone for loss of consciousness are 2.5 to 4.5 mg/ml, and the blood 
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concentrations (when combined with nitrous oxide) required for surgery are 2.5 to 8 
mg/ml. Similar concentrations are necessary when propofol is combined with an opioid for 
a total intravenous technique.· The knowledge of these levels and of the pharmacokinetics 
of propofol has enabled the use of pharmacokinetic model-driven infusion systems to 
deliver propofol as a continuous infusion for the maintenance of anesthesia. For short 
(hour) body surface procedures, the advantages of a more rapid recovery and decreased 
nausea and vomiting are still evident (Doze VA et a/, 1988) However, if propofol is used 
for longer or more major procedures, both speed of recovery and the incidence of nausea 
and vomiting are similar to those following thiopental-isoflurane anesthesia (Doze VA et 
al, 1988). 
2.1.6.2 Sedation 
Propofol has been evaluated for sedation during surgical procedures and for patients 
receiving mechanical ventilation in the ICU. Propofol by continuous infusion provides a 
readily titratable level of sedation and a rapid recovery once infusion is terminated 
irrespective of the duration of the infusion (Beller JP et a/, 1988). In a study of patients 
sedated in the ICU for 4 days with propofol, recovery to consciousness was rapid (about 10 
minutes). Both the rate of recovery and decrease in plasma concentration were similar at 
24 and at 96 hours, when the infusion was discontinued. Also, the plasma concentrations 
required for sedation and for awakening were similar at 24 and 96 hours, which implies 
that tolerance to propofol did not occur (Beller JP eta/, 1988). As noted above, there have 
been more recent reports of tolerance with propofol. Infusion rates required for sedation to 
supplement regional anesthesia in healthy patients are half or less than half of those 
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required for general anesthesi~ (i.e., 30 to 60 mg!kg/min) (Fanard L et al, 1988). In elderly 
patients (over 65 years) and sicker patients the infusion rates that are necessary are 
markedly reduced (Grounds RM et al, 1985). Thus, it is important to individually titrate 
the infusion to the desired effect. A 1992 report has linked propofol with several deaths in 
children requiring sedation for mechanical ventilation secondary to upper respiratory tract 
infections (Parke TJ eta/, 1992). The likelihood of propofol being the primary cause has 
been challenged. However, propofol is not yet approved for ICU sedation in children, and 
it should not be used for this purpose until definitive studies assessing its safety in this 
population are completed. No such adverse experiences have been reported in adults. A 
potential advantage for propofol for sedation of ICU patients is that it appears to possess 
antioxidant properties (Murphy PG et al, 1992). 
Generally at propofol infusion rates greater than 3 0 mg/kg/min patients are 
amnestic (Fanard L et a/, 1988). In comparison with midazolam used to maintain sedation, 
propofol provides equal or better control and more rapid recovery (Grounds RM et a!, 
1985). In mechanically ventilated patients, more rapid recovery translates to more rapid 
extubation when sedation is terminated. Propofol has also been used successfully in 
patient-controlled sedation. Propofol was rated better.than midazolam when used by this 
technique, probably owing to. its much more rapid onset and offset (Rudkin GE et a!, 
1992). 
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2.1.6.3 Ambulatory anaesthesia 
The ideal anaesthetic technique for ambulatory surgery should provide rapid onset and 
stable operating conditions while ensuring rapid recovery of protective reflexes and of 
cognitive and psychomotor functions. In evaluating recovery from anaesthesia from in the 
outpatient setting, it is common to divide the recovery process into three distinct phases. 
Early recovery is usually referred to as emergence, and describes the time at which the 
patients awakenes from anaesthesia and obeys simple commands. Intermediate recovery 
describes the return of cognitive function and psychomotor function sufficient to permit 
discharge. Late recovery describes a complete return to preoperative state and resumption 
of normal activities. Anaesthetic techniques used in the ambulatory setting should be 
associated with a low incidence of postoperative side effects because they can delay the 
patient discharge and result in unanticipated hospital admissions. Since its introduction 
into clinical practice, propofol has become extremely popular intravenous anaesthetic for 
ambulatory surgery procedures because of its predictable recovery and favorable side 
effects profile. Recovery is not only rapid after a single bolus dose, but also after repeated 
doses or a titrated continuous infusion, thereby allowing propofol to be effectively used for 
maintenance of anaesthesia during ambulatory surgical procedures. 
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2.1.6.4 Monitored anaesthesia care 
Monitored anaesthesia care usually involves the administration of intravenous adjuvants to 
produce sedation, anxiolysis and amnesia during minor diagnosis and therapeutic 
procedures or to supplement analgesic provided by local or regional anaesthetic technique. 
During monitored anaesthesia procedures, patients are monitored to ensure their safety and 
comfort during the operation. With the optimum sedation technique, the chosen drug (or 
combination of drugs) has sedative-hypnotic, anxiolytic, and amnestic properties, produces 
a low incidence of peri operative side effect (e.g., respiratory depression, nausea and 
vomiting), provides ease of titration to the desired level of sedation while providing rapid 
return completion of the procedure to a "clearheaded" state on completion of the 
procedure. 
Traditionally, benzodiazepines have been widely used drug for sedation during monitored 
anaesthesia care. However, even drugs like midazolam or triazolam with relatively short 
elimination half-life values (2 to 4 hours) may be associated with prolonged sedation, and 
the resultant psychomotor impairment can delay recovery (Urquhart :ML et a!, 1989). 
Opiod .analgesic (e.g. fentanyl and its newer arialogs) are often administered in 
combination with sedative-hypnotics to reduce pain resulting from the injection of local 
anaesthetic solutions and traction on deeper tissue structure~. Although a combination of 
midazolam and fentanyl is the most popular regimen, this combination can produce 
profound respiratory depression (Bailey PL et al, 1990). Compared with nonsteroidal anti-
inflammatory ketorolac, adjunctive use of fentanyl provided for improved intraoperative 
patient comfort during propofol sedation (Ramirez-Ruiz M et al, 1995). However, when 
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